Canadian Investment Banking Group: Maintaining the Guardant Health (GH.US) rating, adjusted from buy to buy rating, and adjusted the target price from $45.00 to $30.00.
Zhitong FinanceApr 29 22:40
Guardant Health Analyst Ratings
BenzingaApr 29 22:35
Guardant Health Analyst Ratings
BenzingaApr 25 01:33
Craig-Hallum Assumes Guardant Health at Buy, Announces Price Target of $28
BenzingaApr 25 01:34
Guardant Health Analyst Ratings
BenzingaApr 15 22:24
Guardant Health Analyst Ratings
BenzingaApr 5 22:04
Buy Rating Affirmed for Guardant Health Amid Strong Shield Test Prospects and Positive ECLIPSE Study Results
TipRanksMar 14 19:18
Analysts' Opinions Are Mixed on These Healthcare Stocks: Guardant Health (GH), Cue Health (HLTH) and Skye Bioscience (OtherSKYE)
TipRanksMar 14 19:10
BTIG Keeps Their Buy Rating on Guardant Health (GH)
TipRanksFeb 27 18:25
Piper Sandler Cuts Price Target on Guardant Health to $30 From $40, Maintains Overweight Rating
MT NewswiresFeb 27 00:21
Guardant Health Analyst Ratings
BenzingaFeb 26 22:50
Scotiabank Keeps Their Buy Rating on Guardant Health (GH)
TipRanksFeb 26 20:16
UBS Adjusts Guardant Health Price Target to $32 From $45, Maintains Buy Rating
MT NewswiresFeb 24 01:06
Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $45
BenzingaFeb 23 22:42
Guardant Health Analyst Ratings
BenzingaFeb 23 22:41
Stifel Nicolaus Remains a Buy on Guardant Health (GH)
TipRanksFeb 23 20:32
Buy Rating Affirmed for Guardant Health Amidst Conservative FY24 Guidance and Promising Growth Prospects
TipRanksFeb 23 18:17
Guardant Health Buy Rating Affirmed Amidst Conservative Guidance and Undervalued Base Business
TipRanksFeb 23 11:55
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), IQVIA Holdings (IQV) and Ascendis Pharma (ASND)
TipRanksFeb 20 21:41
Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $37
BenzingaJan 30 21:58
No Data
No Data